| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Implantable Pulmonary Artery Pressure Measurement Device | 2024-04-29 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Pain Management by Injection | 2024-04-29 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Spesolimab (Spevigo) | 2024-04-29 |
| BCBS Highmark Penn Medicare Advantage | 4Kscore Test Algorithm | 2024-04-29 |
| BCBS Highmark Penn Medicare Advantage | Amivantamab-vmjw (Rybrevant) | 2024-04-29 |
| BCBS Highmark Penn Medicare Advantage | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |
| BCBS Highmark NY and West NY | Implantable Pulmonary Artery Pressure Measurement Device | 2024-04-29 |
| BCBS Highmark NY and West NY | New York Oncology Mandate | 2024-04-29 |
| BCBS Highmark NY and West NY | Inotuzumab Ozogamicin (Besponsa) | 2024-04-29 |